D-0496-2026 Class II Ongoing

Recalled by B BRAUN MEDICAL INC — Allentown, PA

FDA drug recall D-0496-2026 was initiated by B BRAUN MEDICAL INC on Apr 2, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed. The recall status is ongoing. Affected quantity: 17,124 bags.

Recall details

Product Type
Drugs
Report Date
Apr 29, 2026
Initiation Date
Apr 2, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17,124 bags

Product description

DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC: 0264-7387-50.

Reason for recall

Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.

Distribution pattern

US Nationwide.

Code information

Lot # J5H166, J5H167, Exp Date: 30NOV2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0496-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0496-2026. Report a data issue: hello@regdatalab.com.